Literature DB >> 18040804

Nuclear factor kappaB signaling in opioid functions and receptor gene expression.

Yulong L Chen1, Ping-Yee Law, Horace H Loh.   

Abstract

Opiates are the most powerful of all known analgesics. The prototype opiate morphine has been used as a painkiller for several thousand years. Chronic usage of opiates not only causes drug tolerance, dependence, and addiction, but also suppresses immune functions and affects cell proliferation and cell survival. The diverse functions of opiates underscore the complexity of opioid receptor signaling. Several downstream signaling effector systems, including adenylyl cyclase, mitogen-activated protein kinase, Ca2+ channels, K+ channels, and phosphatidylinositol 3-kinase/Akt, have been identified to be critical in opioid functions. Nuclear factor-kappaB (NF-kappaB), one of the most diverse and critical transcription factors, is one of the downstream molecules that may either directly or indirectly transmit the receptor-mediated upstream signals to the nucleus, resulting in the regulation of the NF-kappaB-dependent genes, which are critical for the opioid-induced biological responses of neuronal and immune cells. In this minireview, we focus on current understanding of the involvement of NF-kappaB signaling in opioid functions and receptor gene expression in cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 18040804      PMCID: PMC3446243          DOI: 10.1007/s11481-006-9028-0

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  119 in total

1.  NF-kappaB, nitric oxide and opiate signaling.

Authors:  I D Welters; C Fimiani; T V Bilfinger; G B Stefano
Journal:  Med Hypotheses       Date:  2000-02       Impact factor: 1.538

Review 2.  Nitric oxide: an inhibitor of NF-kappaB/Rel system in glial cells.

Authors:  M Colasanti; T Persichini
Journal:  Brain Res Bull       Date:  2000-06       Impact factor: 4.077

Review 3.  Molecular mechanisms and regulation of opioid receptor signaling.

Authors:  P Y Law; Y H Wong; H H Loh
Journal:  Annu Rev Pharmacol Toxicol       Date:  2000       Impact factor: 13.820

Review 4.  Crosstalk between nervous and immune systems through the animal kingdom: focus on opioids.

Authors:  M Salzet; D Vieau; R Day
Journal:  Trends Neurosci       Date:  2000-11       Impact factor: 13.837

5.  Expression of delta opioid receptors by splenocytes from SEB-treated mice and effects on phosphorylation of MAP kinase.

Authors:  N A Shahabi; K McAllen; S G Matta; B M Sharp
Journal:  Cell Immunol       Date:  2000-11-01       Impact factor: 4.868

6.  Morphine inhibits NF-kappaB nuclear binding in human neutrophils and monocytes by a nitric oxide-dependent mechanism.

Authors:  I D Welters; A Menzebach; Y Goumon; P Cadet; T Menges; T K Hughes; G Hempelmann; G B Stefano
Journal:  Anesthesiology       Date:  2000-06       Impact factor: 7.892

7.  Mu opioid receptor expression is increased in inflammatory bowel diseases: implications for homeostatic intestinal inflammation.

Authors:  D Philippe; D Chakass; X Thuru; P Zerbib; A Tsicopoulos; K Geboes; P Bulois; M Breisse; H Vorng; J Gay; J-F Colombel; P Desreumaux; M Chamaillard
Journal:  Gut       Date:  2005-11-18       Impact factor: 23.059

8.  Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence.

Authors:  L M Bohn; R R Gainetdinov; F T Lin; R J Lefkowitz; M G Caron
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

Review 9.  Apoptosis in the nervous system.

Authors:  J Yuan; B A Yankner
Journal:  Nature       Date:  2000-10-12       Impact factor: 49.962

10.  Reciprocal developmental changes in the roles of Bcl-w and Bcl-x(L) in regulating sensory neuron survival.

Authors:  G Middleton; S Wyatt; N Ninkina; A M Davies
Journal:  Development       Date:  2001-02       Impact factor: 6.868

View more
  26 in total

1.  Ammonium pyrrolidine dithiocarbamate and RS 102895 attenuate opioid withdrawal in vivo and in vitro.

Authors:  Ashish K Rehni; Nirmal Singh
Journal:  Psychopharmacology (Berl)       Date:  2011-09-20       Impact factor: 4.530

Review 2.  Roles for NF-κB and gene targets of NF-κB in synaptic plasticity, memory, and navigation.

Authors:  Wanda M Snow; Brenda M Stoesz; Debbie M Kelly; Benedict C Albensi
Journal:  Mol Neurobiol       Date:  2013-10-13       Impact factor: 5.590

3.  Use of Flavored Tablets of Gabapentin and Carprofen to Attenuate Postoperative Hypersensitivity in an Incisional Pain Model in Rats (Rattus norvegicus).

Authors:  Brian P Zude; Katechan Jampachaisri; Cholawat Pacharinsak
Journal:  J Am Assoc Lab Anim Sci       Date:  2020-02-19       Impact factor: 1.232

4.  PI3K-Akt1 expression and its significance in liver tissues with chronic fluorosis.

Authors:  Bin Fan; Yanni Yu; Ying Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

Review 5.  Neuroprotection against hypoxia/ischemia: δ-opioid receptor-mediated cellular/molecular events.

Authors:  Xiaozhou He; Harleen K Sandhu; Yilin Yang; Fei Hua; Nathalee Belser; Dong H Kim; Ying Xia
Journal:  Cell Mol Life Sci       Date:  2012-09-27       Impact factor: 9.261

6.  Toll-like receptor 4-mediated nuclear factor-κB activation in spinal cord contributes to chronic morphine-induced analgesic tolerance and hyperalgesia in rats.

Authors:  Liying Bai; Caihong Zhai; Kun Han; Zhisong Li; Junliang Qian; Ying Jing; Wei Zhang; Ji-Tian Xu
Journal:  Neurosci Bull       Date:  2014-12-02       Impact factor: 5.203

7.  Chronic morphine-induced microRNA-124 promotes microglial immunosuppression by modulating P65 and TRAF6.

Authors:  Shuwei Qiu; Yimin Feng; Gene LeSage; Ying Zhang; Charles Stuart; Lei He; Yi Li; Yi Caudle; Ying Peng; Deling Yin
Journal:  J Immunol       Date:  2014-12-24       Impact factor: 5.422

8.  Effect of chronic delivery of the Toll-like receptor 4 antagonist (+)-naltrexone on incubation of heroin craving.

Authors:  Florence R Theberge; Xuan Li; Sarita Kambhampati; Charles L Pickens; Robyn St Laurent; Jennifer M Bossert; Michael H Baumann; Mark R Hutchinson; Kenner C Rice; Linda R Watkins; Yavin Shaham
Journal:  Biol Psychiatry       Date:  2013-02-04       Impact factor: 13.382

9.  Mu-opioid signaling modulates biphasic expression of TrkB and IκBα genes and neurite outgrowth in differentiating and differentiated human neuroblastoma cells.

Authors:  Aiyun Wen; Abra Guo; Yulong L Chen
Journal:  Biochem Biophys Res Commun       Date:  2013-02-16       Impact factor: 3.575

10.  Mu-opioid receptors transiently activate the Akt-nNOS pathway to produce sustained potentiation of PKC-mediated NMDAR-CaMKII signaling.

Authors:  Pilar Sánchez-Blázquez; María Rodríguez-Muñoz; Javier Garzón
Journal:  PLoS One       Date:  2010-06-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.